Abbott Laboratories reports results for the quarter ended September 30 - Earnings Summary

Abbott Laboratories

21/10/2026 14:32

Abbott Laboratories ABT.N reported quarterly adjusted earnings of $1.42​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $1.30.  The mean expectation of twenty six analysts for the quarter was for earnings of $1.42 per share. Wall Street expected results to range from $1.31  to $1.44 per share.
Revenue rose 14.5% to $13.01 billion from a year ago; analysts expected $13.00 billion. 
Abbott Laboratories's reported EPS for the quarter was 53 cents​.
The company reported quarterly net income of $920 million.
Abbott Laboratories shares had risen by 3.7% this quarter and lost 18.2% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 0.2% in the last three months.​ 
In the last 30 days, two analysts negatively revised earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 25 "strong buy" or "buy," 4 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy" 
Wall Street's median 12-month price target for Abbott Laboratories is $120.50, about 15% above its last closing price of $102.45
This summary was machine generated from LSEG data October 21 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Sep. 30 2026 
1.42
1.42
Met
Jun. 30 2026 
1.28
1.31
Beat
Mar. 31 2026 
1.14
1.15
Beat
Dec. 31 2025 
1.50
1.50
Met